Esperion Therapeutics, Inc. (ESPR)

Esperion Therapeutics Revenue

Esperion Therapeutics had revenue of $82.39M in the quarter ending June 30, 2025, with 11.58% growth. This brings the company's revenue in the last twelve months to $268.13M, down -3.48% year-over-year. In the year 2024, Esperion Therapeutics had annual revenue of $332.31M with 185.66% growth.

• Revenue (ttm): $268.13M
• Revenue Growth: -3.48%
• P/S Ratio: 1.31
• Revenue / Employee: $881,990
• Employees: 304
• Market Cap: 378.38M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	332.31M	215.98M	185.66%
Dec 31, 2023	116.33M	40.86M	54.14%
Dec 31, 2022	75.48M	-2.97M	-3.79%
Dec 31, 2021	78.45M	-149.10M	-65.52%
Dec 31, 2020	227.55M	79.18M	53.37%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.